Project Grant R01DE033893
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded The Trustees of Columbia University in the City of New York a $655,455 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) on September 11, 2025, with a completion date of September 10, 2027. This R01 renewal grant supports basic and translational research to identify temporomandibular joint (TMJ) cartilage progenitor cells and characterize their regulatory...
- This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research (CFDA 93.121) program, aims to elucidate the role of TGF-beta signaling in craniofacial fibrous dysplasia (CFD), a debilitating skeletal disease. With total funding of $306,600 awarded on September 24, 2024, the project will investigate the mechanisms driving TGF-beta signaling in response to constitutive activation of G-protein coupled receptor...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded The Children's Hospital of Philadelphia Research Institute a Project Grant of $507,006 (awarded August 1, 2025, with completion by July 31, 2027) under the Oral Diseases and Disorders Research program (CFDA 93.121). This research initiative investigates the role of hyaluronan (HA) in YAP (Yes-associated protein) signaling and temporomandibular joint (TMJ) health and pathology. The project...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded Massachusetts General Hospital $408,951 under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop and validate Photochemical Tissue Passivation (PTP) as a therapeutic approach to reduce temporomandibular joint (TMJ) osteoarthritis progression. The research project, which commenced February 15, 2026 and concludes February 14, 2028, involves the application of rose...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research awarded Columbia University's Health Sciences Division $738,929 under the Oral Diseases and Disorders Research program (CFDA 93.121) beginning August 1, 2025, with completion targeted for April 30, 2030. This Project Grant supports the development and validation of a patient-specific temporomandibular joint (TMJ)-on-a-chip model designed to investigate multi-tissue crosstalk regulating TMJ disc injury and...
- This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will provide $429,000.00 to the Regents of the University of Michigan to conduct research on the unique characteristics of jawbone biology. The research aims to gain a molecular-level understanding of how osteoblasts in the jawbone respond differently to bone morphogenetic protein (BMP) signaling and mechanical loading...
- This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support research to establish a novel zebrafish model of syndromic craniosynostosis. The $313,000 award to Emory University will enable comprehensive phenotypic, mechanistic, and genetic analyses of the craniosynostosis mutant zebrafish to better understand the underlying pathological mechanisms. The research aims to identify...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded the Board of Regents of the University of Nebraska, operating through its University of Nebraska Medical Center (UNMC) division, a Project Grant totaling $419,379 under the Oral Diseases and Disorders Research program (CFDA 93.121). The award, obligated on August 8, 2025, with a completion date of May 31, 2030, supports fundamental research investigating the molecular mechanisms by which...
- This Project Grant award, with an ID of R01DE032676, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $2,372,115 award, spanning from July 2024 to June 2027, supports research to identify and validate the lysophosphatidic acid (LPA)/LPA receptor (LPAR) signaling pathway as a novel target for the treatment of temporomandibular disorder (TMD) pain. The primary research objectives are to: 1)...
- This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research (CFDA 93.121) federal grant program, will fund research at the University of Pittsburgh to investigate the role of the TRPS1 transcription factor in regulating the formation and mineralization of dental tissues. The $593,468 award, spanning September 2024 to September 2026, aims to (1) determine how TRPS1 regulates communication between developing...
ROLE OF LGR+ CONNECTIVE TISSUE PROGENITORS IN TMJ DEVELOPMENT - PROJECT SUMMARY ACCORDING TO NIDCR, TEMPOROMANDIBULAR JOINT (TMJ) DISORDERS AFFECT UP TO 12% OF THE POPULATION AND ARE A MAJOR PRIORITY FOR FURTHER RESEARCH. THE HIGH INCIDENCE IN CHILDREN IS UNUSUAL FOR A CHRONIC PAIN CONDITION, SUGGESTING A SIGNIFICANT DEVELOPMENTAL ORIGIN. TMJ DEVELOPMENT INVOLVES PRECISE PATTERNING OF THE MANDIBULAR BONY PROCESSES AND DIVERSE CONNECTIVE TISSUES INCLUDING THE FIBROUS DISC, STABILIZING LIGAMENTS, AND TENDONS THAT CONNECT TO JAW MUSCLES. SKELETAL AND SOFT CONNECTIVE TISSUE STRUCTURES OF THE TMJ DERIVE FROM CRANIAL NEURAL CREST CELLS, YET HOW CELL FATE DECISIONS ARE BALANCED TO GENERATE THE CORRECT TISSUES WITH SPATIAL PRECISION REMAINS UNRESOLVED. IN A PREVIOUSLY FUNDED R21, PIS GAGE CRUMP AND AMY MERRILL COMBINED SINGLE-CELL OMICS WITH ZEBRAFISH AND MOUSE GENETICS TO IDENTIFY A NEW FUNCTION OF THE NUCLEAR RECEPTOR NR5A2 IN PROMOTING CONNECTIVE TISSUE AT THE EXPENSE OF SKELETAL FATES AT THE DEVELOPING TMJ. HOWEVER, THE IDENTITY OF THE STEM/PROGENITOR CELLS FOR TMJ CONNECTIVE TISSUES, AND HOW THEY DIFFER FROM SKELETAL STEM CELLS, WAS UNKNOWN. HERE, BY ANALYZING NEW SINGLE-CELL DATA OF THE DEVELOPING MOUSE TMJ, WE HAVE IDENTIFIED THE R-SPONDIN RECEPTORS LGRS AS MARKERS OF JAW CONNECTIVE TISSUE STEM CELLS. COMPARED TO ROLES IN EPITHELIAL STEM CELL BIOLOGY, POTENTIAL ROLES OF LGRS IN MESENCHYMAL TISSUES HAVE BEEN UNDERSTUDIED. WE PROPOSE THAT LGRS FUNCTION TO MAINTAIN THE STEM POOL FOR SUSTAINED CONNECTIVE TISSUE GENERATION AT THE TMJ BY POTENTIATING LOCALLY HIGH WNT SIGNALING. IN AIM 1, WE WILL PERFORM LINEAGE TRACING TO TEST THAT LGR4 AND LGR5 IN MOUSE, AND LGR4 AND LGR6 IN ZEBRAFISH, MARK CONNECTIVE TISSUE STEM CELLS AT BOTH EMBRYONIC AND POSTNATAL STAGES. WE WILL ALSO USE TARGETED ABLATION TO TEST THE REQUIREMENT OF LGR5+ CELLS FOR TMJ CONNECTIVE TISSUE DEVELOPMENT AND POSTNATAL GROWTH. IN AIM 2, WE WILL PERFORM REAL-TIME IN VIVO IMAGING IN DEVELOPING ZEBRAFISH TO TEST THAT CONNECTIVE TISSUE PROGENITORS TRANSITION FROM A HIGH TO LOW WNT STATE AS THEY DIFFERENTIATE INTO TENDONS AND LIGAMENTS. WE WILL THEN USE CONDITIONAL MOUSE GENETICS TO TEST OUR MODEL THAT SUSTAINING WNT SIGNALING IN LGR5+ CELLS DISRUPTS DIFFERENTIATION BY LOCKING CELLS IN A STEM CELL STATE, AND RECIPROCALLY BLOCKING CANONICAL WNT SIGNALING IN LGR5+ CELLS DEPLETES STEM CELLS AND CAUSES A FAILURE TO SUSTAIN CONNECTIVE TISSUE DEVELOPMENT. IN AIM 3, WE USE MOUSE LGR4 AND LGR5 FLOXED ALLELES PROVIDED BY OUR COLLABORATORS AT NOVARTIS, AND NEWLY GENERATED ZEBRAFISH LGR4 AND LGR6 CRISPR MUTANTS, TO TEST THAT LGRS ARE REDUNDANTLY REQUIRED IN LGR5+ CELLS FOR HIGH WNT SIGNALING AND MAINTENANCE OF CONNECTIVE TISSUE PROGENITORS. WE THEN TEST WHETHER RESTORING WNT SIGNALING LEVELS THROUGH GENETIC OR PHARMACOLOGICAL MEANS CAN RESCUE CONNECTIVE TISSUE DEFECTS IN LGR MUTANTS. STRENGTHS OF THE PROPOSAL INCLUDE THE PI TEAM WITH COMPLEMENTARY EXPERTISE IN ZEBRAFISH AND MOUSE MODELS, UNIQUE SINGLE-CELL DATASETS OF THE FISH JAW AND MOUSE TMJ, AND SOPHISTICATED IN VIVO IMAGING AND GENETIC TOOLS IN BOTH SPECIES TO ENABLE MECHANISTIC UNDERSTANDING OF JAW CONNECTIVE TISSUE DIFFERENTIATION. OUR WORK WILL REVEAL HOW ALTERATIONS TO WNT AND STEM CELL FUNCTION IMPACT THE BALANCE OF SKELETAL AND CONNECTIVE TISSUE FORMATION, POTENTIALLY PREDISPOSING TO TMJ DISORDERS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $496.3k | 5/1/25 | ||
| Not listed | $496.3k | 7/10/24 | ||
| Not listed | $496.3k | 7/10/24 |